DrugPatentWatch Database Preview
Ziv-aflibercept - Biologic Drug Details
Summary for ziv-aflibercept
| Tradenames: | 1 |
| Patents: | 8 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for ziv-aflibercept |
Recent Clinical Trials for ziv-aflibercept
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Vastra Gotaland Region | Phase 2 |
| Kodiak Sciences Inc | Phase 2 |
| Graybug Vision | Phase 2 |
Patent Text Search: US Patents for ziv-aflibercept
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | ZALTRAP | ziv-aflibercept | INJECTABLE; INJECTION | 125418 | 001 | 2012-08-03 | Start Trial | The Rockefeller University (New York, NY) | 2032-10-31 | RX | search | |
| Sanofi Aventis Us | ZALTRAP | ziv-aflibercept | INJECTABLE; INJECTION | 125418 | 001 | 2012-08-03 | Start Trial | The Rockefeller University (New York, NY) | 2032-10-31 | RX | search | |
| Sanofi Aventis Us | ZALTRAP | ziv-aflibercept | INJECTABLE; INJECTION | 125418 | 001 | 2012-08-03 | Start Trial | Tyme, Inc. (Wilmington, DE) | 2039-02-26 | RX | search | |
| Sanofi Aventis Us | ZALTRAP | ziv-aflibercept | INJECTABLE; INJECTION | 125418 | 001 | 2012-08-03 | Start Trial | Enzychem Lifesciences Corporation (Seoul, KR) | 2039-02-26 | RX | search | |
| Sanofi Aventis Us | ZALTRAP | ziv-aflibercept | INJECTABLE; INJECTION | 125418 | 001 | 2012-08-03 | Start Trial | The Rockefeller University (New York, NY) | 2032-10-31 | RX | search | |
| Sanofi Aventis Us | ZALTRAP | ziv-aflibercept | INJECTABLE; INJECTION | 125418 | 001 | 2012-08-03 | Start Trial | HANGZHOU DAC BIOTECH CO., LTD. (Hangzhou, CN) | 2035-07-15 | RX | search | |
| Sanofi Aventis Us | ZALTRAP | ziv-aflibercept | INJECTABLE; INJECTION | 125418 | 001 | 2012-08-03 | Start Trial | BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS (GR) | 2035-07-08 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for ziv-aflibercept
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3375440 | Start Trial |
| South Korea | 20170066666 | Start Trial |
| Canada | 3004879 | Start Trial |
| China | 104918659 | Start Trial |
| Australia | 2013337768 | Start Trial |
| Japan | 2018536711 | Start Trial |
| Hong Kong | 1215000 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
